摘要
目的探讨复杂性尿路感染的致病菌分布和耐药性特点、临床治疗情况。方法回顾性分析60例复杂性尿路感染患者的临床资料。结果60例患者中,大肠埃希菌42株占70%,表皮葡萄球菌和肠球菌各6株,检出率均为10%,肺炎克雷伯杆菌3株占5%;另有3例尿真菌培养阳性,占5%。42株大肠埃希菌对亚胺培南、阿米卡星、呋喃妥因的耐药率较低,依次为8%、5%、5%,而对喹诺酮类、头孢菌素类、氨苄西林的耐药率较高。结论大肠埃希菌仍是住院复杂性尿路感染的主要致病菌,常呈多重耐药,临床治疗应根据药敏试验调整抗菌药。
Objective To investigate the antimicrobial resistance and therapy of patogens causing complicated urinary tract infection. Methods Retrospect analysis of 60 cases of culture -positive hospitalized complicated urinary tract patients from 2000 to 2004. Results E. coli accouted for 70%, S epidermidis, Enterococci separately accouted for 10%, and fungi accounted for 5%. Imipenem, amicacine, furadantin had lower antimicrobial resistance（8%, 5%, 5%）, and quinolones, cephalosporin, ampicillin had higher anti- microbial resistance. Conclusion E. coli is still the most important bacterial in the pathogen of complicated urinary tract infection, and antimicrobial therapy should be initiated under the guidance of anti-microbial sensitivity test if possible.
出处
《国际医药卫生导报》
2005年第22期44-45,共2页
International Medicine and Health Guidance News
关键词
尿路感染
复杂性
细菌
药敏试验
Urinary tract infection complicated Bacteria Resistance
